HCA Healthcare Inc (NYSE:HCA) was the recipient of some unusual options trading on Wednesday. Investors purchased 3,329 put options on the company. This is an increase of 1,237% compared to the average daily volume of 249 put options.
In related news, SVP Victor L. Campbell sold 8,000 shares of the company’s stock in a transaction dated Wednesday, November 8th. The stock was sold at an average price of $78.00, for a total value of $624,000.00. Following the completion of the sale, the senior vice president now directly owns 127,275 shares of the company’s stock, valued at approximately $9,927,450. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Michael S. Cuffe sold 2,400 shares of the company’s stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $86.63, for a total value of $207,912.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 20,550 shares of company stock valued at $1,606,172. Insiders own 2.90% of the company’s stock.
Institutional investors have recently bought and sold shares of the business. Strs Ohio raised its stake in shares of HCA Healthcare by 12.2% during the 3rd quarter. Strs Ohio now owns 1,075,778 shares of the company’s stock worth $85,621,000 after buying an additional 117,000 shares in the last quarter. AustralianSuper Pty Ltd purchased a new position in shares of HCA Healthcare during the 3rd quarter worth approximately $24,410,000. Yellowstone Partners LLC purchased a new position in shares of HCA Healthcare during the 3rd quarter worth approximately $5,802,000. Toronto Dominion Bank raised its stake in shares of HCA Healthcare by 12.8% during the 3rd quarter. Toronto Dominion Bank now owns 112,657 shares of the company’s stock worth $8,965,000 after buying an additional 12,744 shares in the last quarter. Finally, Micawber Capital LLC raised its stake in shares of HCA Healthcare by 31.3% during the 3rd quarter. Micawber Capital LLC now owns 34,461 shares of the company’s stock worth $2,743,000 after buying an additional 8,205 shares in the last quarter. 75.35% of the stock is owned by institutional investors.
A number of analysts recently issued reports on HCA shares. Credit Suisse Group reissued an “outperform” rating and issued a $25.00 target price on shares of HCA Healthcare in a research report on Tuesday, December 26th. Robert W. Baird set a $104.00 target price on HCA Healthcare and gave the company a “buy” rating in a research report on Friday, January 12th. Raymond James Financial cut HCA Healthcare from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, October 18th. Morgan Stanley cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $85.00 target price for the company. in a research report on Wednesday, December 20th. Finally, Cantor Fitzgerald reissued a “buy” rating and issued a $95.00 target price on shares of HCA Healthcare in a research report on Friday, October 13th. Three research analysts have rated the stock with a sell rating, six have given a hold rating and seventeen have given a buy rating to the company. HCA Healthcare has a consensus rating of “Buy” and an average price target of $88.32.
Shares of HCA Healthcare (HCA) opened at $93.01 on Friday. HCA Healthcare has a 1 year low of $71.18 and a 1 year high of $93.32. The company has a debt-to-equity ratio of -6.46, a quick ratio of 1.41 and a current ratio of 1.68. The firm has a market capitalization of $33,600.00, a P/E ratio of 13.23, a price-to-earnings-growth ratio of 1.18 and a beta of 0.55.
HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, October 31st. The company reported $1.21 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.21. HCA Healthcare had a negative return on equity of 47.16% and a net margin of 6.13%. The company had revenue of $10.70 billion during the quarter, compared to analysts’ expectations of $10.70 billion. During the same period last year, the firm earned $1.45 EPS. The firm’s revenue for the quarter was up 4.1% on a year-over-year basis. equities analysts predict that HCA Healthcare will post 6.56 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: “Stock Traders Buy High Volume of Put Options on HCA Healthcare (HCA)” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/01/20/stock-traders-buy-high-volume-of-put-options-on-hca-healthcare-hca.html.
About HCA Healthcare
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.